As a result of the coronavirus pandemic, the RCVS has announced various changes to the timetable for its review of ‘under care’, remote prescribing and 24/7 out-of-hours emergency cover.

As part of its review, the College had planned a series of focus groups of veterinary surgeons and nurses across the UK. However, these have had to be delayed both because of social distancing rules and because of the pressures that practice teams are currently working under. However, the agency tasked with hosting the focus groups is now exploring alternative options and it is hoped there will be a revised timetable soon. 

In the meantime, the College says it now plans to commission an additional independent agency to survey veterinary surgeons about their experience of remote prescribing during lockdown. 

In March, RCVS Council agreed to temporarily allow veterinary surgeons to prescribe prescription-only veterinary medicines remotely, without first having physically examined the animal, subject to a number of conditions and safeguards being in place.

This position is due for review by 30th June, and the College will be looking for feedback and data from veterinary surgeons about your experience of remote prescribing, in order to determine whether these arrangements can continue, with or without any extra safeguards.

Because remote prescribing is also one of the most important aspects of the planned under care review, feedback gathered now will help inform future discussions too.

RCVS President Niall Connell said: “We recognise the current conditions that veterinary practices are working under in no way represent normal practice life. Most practices will not have been set up to offer remote services and remote prescribing in a way that they might have chosen, given sufficient time and appropriate detailed guidance, if indeed there are any future guidance changes after the review.

"However, we feel it would be remiss of us not to seize the opportunity arising from this current crisis to ask about the experiences – good or bad – of those on the frontline of clinical veterinary practice in providing remote services to their clients.

"Whilst this will be no substitute for the formal evidence gathered by the research agency in due course, whatever data and feedback we can collate from veterinary practices at this unique time for our professions will, I’m sure, be extremely valuable to our ongoing discussions."

Research carried out by YouGov on behalf of the Dogs Trust, has shown that as the cost of living crisis develops, 68% of dog owners in the UK feel worried, to some extent, about how they will care for their dog in the next year, with 30% either ‘very’ or ‘fairly’ worried.

35% think the rising cost of living is already making it more difficult to give their dogs all they need.

By far the greatest worry was how they would manage to pay vet bills, which 49% named as their main concern.

The second biggest worry was affording dog food (17%), closely followed by insurance (15%).

Non-dog owners in the UK, meanwhile, were asked whether the rising cost of living would prevent them from adopting or buying a dog. Over half (54%) said that it would.

The Dogs Trust says this research mirrors its own experience, seeing a steady increase in the number of requests from owners who have decided to give up their dog.

It harks back to the year after the 2008 recession, when the increase in the number of stray and abandoned dogs reached over 25% in the UK.

Owen Sharp, Dogs Trust CEO, said: "We know from the experience of the 2008 recession that economic crisis can and will lead to people needing to give up their beloved dogs. Sadly, many loving dog owners simply won’t be able to afford to keep them.

“At Dogs Trust we’re rehoming and fostering dogs as quickly as we can - but as soon as we free up a kennel space, there’s a dog to fill it again.

“We’ve already taken 13,000 calls this year from owners who need to give up their dogs – a 58% increase on last year.

“We know that dog owners need immediate help and we’re working hard to find ways to support them - but it takes time.

“However, there are other ways we help, like our Hope Project, which aims to keep anyone experiencing a housing crisis and their dog together, and helping people find other services such as pet food banks or local charities that could ease the burden.”  

“We want dog owners to realise that they don’t have to wait until they are in crisis to call us for help.”

The Veterinary Medicines Directorate is inviting feedback from vets and other interested parties about the legislation which regulates the manufacture, marketing, supply and distribution of veterinary medicines. 

The review will consider whether the UK Veterinary Medicines Regulations 2013, which were were originally derived from EU legislation, protect animal and public health without adding unnecessary regulatory burden.

Anyone is able to share their views and experiences of the regulations, but the VMD is especially interested in hearing from vets, vet nurses, SQPs, marketing authorisation holders, farmers and pet owners.

Responses must be submitted before 23:59 on 26th September 2025

https://consult.defra.gov.uk/vmd-policy-development-and-delivery-office/mmd-act-2021-stakeholder-survey 

The RCVS Disciplinary Committee has reprimanded Anglesey-based Louise Marie Henry MRCVS for writing a letter on behalf of a client that dishonestly certified incorrect details surrounding the death of a ewe.

Dr Henry faced one charge, that in January 2020 she wrote and/or signed an undated letter confirming that a ewe had died in transit to the surgery due to dystocia and peri-parturient stress, when in fact she had euthanised the animal at the veterinary practice the day before. The letter, which was addressed 'To whom it may concern’, was on practice letterheaded paper and signed "Louise Henry MRCVS". 

The second part of the charge outlined that her conduct concerning the letter was dishonest.

The Committee heard that the ewe was lambing and brought to the practice by a client. Dr Henry was on-call at the time and advised a Caesarean section. The client agreed and Dr Henry delivered two live lambs and one dead lamb.

Dr Henry was concerned about the welfare of the ewe post-surgery because of the risk of peritonitis and advised that the ewe should be euthanised.

The client agreed to the ewe being euthanised and then asked Dr Henry to write a letter in which it was stated that the ewe had died in transit on route to the practice. Dr Henry agreed to write the letter in which she falsely certified that the ewe had died in transit. 

The letter came to light when the practice director found it in an insurance file. The practice arranged an investigatory meeting with Dr Henry where she admitted that writing the letter was an error of judgement. When asked about her conduct, Dr Henry explained that the client had subsequently been dissatisfied with the letter she had written and asked her to change it. She refused to amend the letter and told him that it was wrong of her to have written it in the first place and that she regretted having done so.

Dr Henry told the Committee that she valued integrity very highly and that she was deeply ashamed that she had been prepared to write the dishonest letter.

The Committee heard several testimonials from people who had worked with or studied alongside Dr Henry, who all attested to her skill as a veterinary surgeon and that they had no concerns about her integrity and honesty. She self-reported her actions from January to the RCVS and from the outset admitted the facts of the charge. During the hearing, Dr Henry submitted that her action of dishonest false certification amounted to disgraceful conduct in a professional respect.

Dr Martin Whiting, chairing the Committee, and speaking on its behalf, said: “The Committee considered that, in this case, the aggravating features were limited and the mitigating factors extensive. There was no premeditated dishonesty or financial gain involved, there was no actual harm or risk of harm to an animal or human and this was a single incident in an otherwise unblemished 13-year career. The Committee found that the shame and remorse expressed by Dr Henry were entirely genuine. Her conduct on this occasion was entirely untypical of her practise.

“After careful consideration, the Committee concluded that the substantial mitigating features permitted it to take the somewhat unusual course of issuing a reprimand in a case involving dishonesty. In taking this course, the Committee attached significant weight not only to the isolated nature of the event but also to the genuine insight shown by Dr Henry and the lasting impact this event has had upon her. In the Committee’s assessment, a reasonable and fully informed member of the public would, in this particular case, regard a reprimand as a sanction which protected the public interest in the profession and upheld its standards.”

The full documentation for the hearing can be found at www.rcvs.org.uk/disciplinary

Bayer Animal Health has announced it'll be running the 'Be Lungworm Aware' campaign in April 2011. The campaign is targeted at dog owners to raise awareness of the risks associated with the lungworm Angiostrongylus vasorum. 

A Bayer spokesman said: "Over the past years, the spread of A. vasorum has been cited by independent experts, and disease caused by this parasite is increasingly diagnosed. Previous lungworm awareness campaigns have been successful in increasing dog owner awareness of A. vasorum and how their dogs can become infected. However, there is still a lack of recognition as to the signs associated with this infection, so the continuing education of dog owners is extremely important."

The national 'Be Lungworm Aware' activity for April includes TV, radio and print advertising in the form of an educational 'public information' style feature. A national awareness day is also planned for 6 April, which will include radio broadcast and web chat TV, and feature veterinary surgeon Luke Gamble and TV presenter Jenni Falconer.

Bayer has produced a package of veterinary support materials to allow practices to take part in the campaign and raise awareness at a local level. Materials include: an educational waiting room wall display and DVD, and client leaflets. A PR pack has also been produced which contains useful images and information which can be used on websites and in newsletters, as well as a press release for issuing to the local media and radio stations. To order these support materials, practices should contact their local Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.

Norbrook has launched Loxicom 0.5mg/ml oral suspension for small dogs, indicated for the alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders.

Loxicom Oral Suspension comes in a clear 15ml bottle which allows vets and clients to monitor levels of the product and re-order when necessary.

Loxicom 0.5mg/ml for Dogs comes with two sizes of syringe, a 1ml syringe graduated from 0.25kg-5kg to treat even the smallest of dog breeds accurately, and a 5ml syringe graduated from 1kg-25kg to treat small and medium dog breeds. The syringes plug securely into the bottle to ensure a tight-fitting connection and minimal leakage when administering the product.

This new oral suspension joins the range of 1.5mg/ml oral suspensions for Dogs and 5mg/ml injections for Dogs and Cats, launched in 2009, and the 0.5mg/ml oral suspension for Cats launched earlier this year at the BSAVA Congress.

Boehringer Ingelheim has re-launched its website www.metacam.co.uk with a redesign which aims to help cat and dog-owning clients identify and manage pain in their pets. 

Brand Manager Dr Amy Scott said: "Because pain is often very difficult for owners to spot, the website highlights some of the common signs that indicate their cat or dog is suffering.

"We have also included a range of additional measures that owners can take to improve the quality of life and maintain the joint health of their pet once Metacam has been prescribed. These include weight management, regular and gentle exercise and alternative therapies such as hydrotherapy or the use of joint supplements such as Seraquin."

The website highlights common painful conditions such as arthritis, as well as more acute scenarios such as post injury or surgery. It also describes the changes in behaviour owners should be aware of that could indicate their pet is in pain, for example reluctance to exercise, change in appetite, displays of aggression or depression.

Amy added: "The correct use of NSAIDs is also an important consideration for effective pain management. To help with this, the website contains a section on Metacam administration for owners, featuring a short video on accurate dosing and treatment."

Registration is now open for the ISFM 2021 World Feline Congress, taking place online from 25th to the 27th June.

The theme this year is 'The ever-complex cat: a multidisciplinary approach to feline medicine', around which there will be a full programme of talks and lectures, including more than 30 hours of CPD.

The main strands for each day are:

• The pancreas: endocrine/exocrine and the impact of obesity
• Gastrointestinal disease, therapeutics and clinical problem solving
• Liver disease, future horizons of gastrointestinal research and renal disease

Keynote speaker Professor Kenneth Simpson, BVM&S, PhD, Chief of the Section of Small Animal Internal Medicine at Cornell University will deliver a series of talks on his specialisms, including gastrointestinal (GI) disease, pancreatitis and liver enzyme interpretation.

Joining him are more than twenty international feline experts who will be considering the cat from all angles, from imaging and clinical pathology to histology.

Nathalie Dowgray, Head of ISFM, said: "We are very excited about the line-up of speakers for this year’s congress, it is a fantastic opportunity for vets to understand the complexity of feline medicine and come away better able to manage difficult cases."

New for this year are live panel sessions in which delegates will be able to join the speakers in expert discussion on key feline topics, as well as opportunities to network and chat directly with leading names in the veterinary industry.

Delegates will also have access to all of the content for six months of on-demand learning after congress ends.

Registration is open now and available at a special early bird rate until March 31st. This year there are bursary places available for veterinary surgeons and students from low-income countries. More information about eligibility and how to apply can be found on the website.

To register, visit: https://icatcare.org/events/isfm-world-feline-congress/ 

A research project funded by The Horse Trust has made important discoveries about how two peptides regulate the inflammatory response in horses. This knowledge could help with the development of improved anti-inflammatory drugs, which are used to treat a wide range of conditions in horses.

The research project was led by Professor Fiona Cunningham at the Royal Veterinary College in Hertfordshire and Dr Karen Rickards at the Donkey Sanctuary in Sidmouth, assisted by Dr Andrew Brooks at the RVC, and by Dr Kirstie Pickles, now at the Royal (Dick) School of Veterinary Studies in Edinburgh.

Inflammation is associated with a wide range of equine diseases, including recurrent airway obstruction, laminitis and sweet itch. Anti-inflammatory drugs, such as glucocorticosteroids, mainly work by blocking the formation and/or actions of compounds produced in the horse's body that cause inflammatory responses. However, these drugs are not always effective and can have unwanted side effects.

This research, funded by The Horse Trust, aimed to find out more about two naturally-occurring peptides - chains of amino acids that are shorter than proteins - known as annexin-1 and CXCL8. Both have been shown to affect the inflammatory response but little research has been done on their effects in horses. In the long term, knowing more about these compounds could help in the development of new anti-inflammatory drugs with fewer side effects.

During inflammation, neutrophils (a type of white blood cell) stick to the cells lining blood vessels and migrate into inflamed tissue, where they ingest and break down harmful agents. Using techniques that mimic these events, CXCL8 was found to cause adherence and migration of horse neutrophils. However, when it was used in combination with another pro-inflammatory substance, neutrophil migration and adherence were markedly decreased.  This suggests that attempts to reduce inflammation by blocking the actions of CXCL8 might not be as beneficial as had been thought.

At the start of the project, the researchers had no information about horse annexin-1, other than its gene sequence, so their first step was to develop a method to detect the peptide in white blood cells. They established that it was present and, as horse annexin-1 has not yet been synthesised, they used a synthetic peptide derived from annexin-1, Ac2-26, to look at the effects on horse neutrophils.

They found that Ac2-26 decreased neutrophil adherence and migration in response to other pro-inflammatory compounds, although at high concentrations the peptide itself caused some cell activation, thereby increasing inflammation. They also found that dexamethasone (a glucocorticosteroid) increased the levels of annexin-1 in cells, indicating that, as in humans, this class of drugs is likely to act in part through the formation of annexin-1.

These findings suggest that the use of compounds which mimic the actions of annexin-1 may have limitations as anti-inflammatory drugs. As glucocorticosteroids partly work by forming annexin-1, further research is needed in order to find out how annexin-1 will act in the horse's body and establish how its formation contributes to the beneficial effects of these drugs.

Professor Cunningham said: "This Horse Trust-funded research has resulted in some very interesting findings about how inflammatory cells are regulated in horses. The receptors that annexin-1 and CXCL8 act upon could be targets for new equine inflammatory drugs, but more research is needed first to fully understand their actions and how they produce these effects."

The team's research has been accepted for publication by the journal Veterinary Immunology & Immunopathology.

Ceva Animal Health has launched a new TV advertising campaign designed to raise awareness of problems owners may face in a multi-cat environment.

The Cat Cabin Fever campaign will run for four weeks.

Ceva says the 20 second TV ads have been designed to strike a chord with viewers who have more than one cat in their household, where 'sometimes sharing just isn't an option'. Highlighted in particular is the Feliway Diffuser which releases natural pheromones into a room to help cats feel at ease, allowing them to cope with stressful situations and prevent unwanted behaviour.  

Malcolm Laurie, head of marketing at Ceva, said: "We know that there are more than 8million cats in the UK and only 2.5million cat households, therefore the majority of households must have more than one cat.

"However, cats are solitary animals, which makes living with other cats difficult at times. This campaign is focused on making the lives of cat owners and their pets as harmonious as possible, including lots of top tips on how to ease any tensions in such an environment."

Ceva has also produced a multi-cat leaflet designed to give owners specific advice on how to provide the correct environment for our feline friends

The advertising campaign will be supported by online competitions, marketing materials for veterinary clinics and retailers, which include a checklist for a cat friendly home, and PR.

For more information, visit: http://www.feliway.co.uk/.

The BSAVA has teamed up with the Links Group to provide veterinary surgeons with free CPD sessions on how to deal with suspected cases of non-accidental injury to small animals.

Members of the profession are of course more likely than most to receive information about violent incidents that constitute abuse against an animal, and research has shown that such cases are often the index case that trigger investigation into violent households.

Jennie Bartholomew, education coordinator at the BSAVA said: "Suspecting animal abuse can be an alarming and sensitive issue to confront but our training courses should give veterinary teams the skills and support they need to help deal with such cases."

The sessions will provide guidance on setting up a practice protocol and identifying a Safeguarding Liaison Officer (SLO) who will aid practice staff in suspected cases of abuse. Through the SLO, relationships with RSPCA officers, police domestic abuse officers and aid agencies can be set up to give staff expert support to call upon if they suspect animal or human abuse.

Freda Scott-Park is a BSAVA Past President and is one of the lecturers on the Links Veterinary Training Initiative courses. She said: "There are few veterinary practices that do not encounter animal abuse, not daily, but the incidence is increasing.

"Cases can be quite complicated to diagnose but often vets find they develop a sixth sense that something isn’t right. By defining the complexities and difficulties in diagnosis, the course aids vets, veterinary nurses and receptionists to understand how to proceed – to ask the right questions and how to seek help from the correct people.

"Information from the veterinary practices may allow human healthcare professionals to investigate troubled households, offering support to the family and potentially improving or saving a human victim’s life."

Three sessions have been organised around the country during 2019. They are free for BSAVA members, with a non-member price of £40.00.

• Sunday 23 June: Wetherby Racecourse, Yorkshire

• Monday 16 September: Woodrow House, Gloucester

• Sunday 27 October: Jesus College, Cambridge

Vétoquinol, manufacturer of Epiphen (phenobarbital), for the control of epilepsy in dogs, has announced the launch of a new starter pack for clients that are embarking on treatment.

The starter packs contain a variety of support materials designed to help owners better understand the condition and its treatment. They sit alongside other support given by the company, which includes an 'Ask the Expert' helpline through which Epiphen veterinary customers can speak to a neurology specialist at The Animal Health Trust in Newmarket, where Vetoquinol sponsors a neurology clinician.

Abbie King, Product Manager for Epiphen, said: ''Our 'Ask the Expert' helpline is a successful service that has been running for several years. 30% of the calls to Vetoquinol's technical team relate to this challenging condition meaning there are few queries our technical team have not tackled before. If extra help is necessary we have an excellent working relationship with The Animal Health Trust and regularly refer cases to them for further advice. We are very proud of this service and are delighted to be able to continue to provide this helpline for our Epiphen clients.''

To use the 'Ask the Expert' service, or order the support materials, ring 0800 1698197. Alternatively visit: www.vetoquinol.co.uk or www.epiphenonline.co.uk.